0001127602-22-003422.txt : 20220204 0001127602-22-003422.hdr.sgml : 20220204 20220204171207 ACCESSION NUMBER: 0001127602-22-003422 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220202 FILED AS OF DATE: 20220204 DATE AS OF CHANGE: 20220204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CONCANNON BRIAN CENTRAL INDEX KEY: 0001261784 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39218 FILM NUMBER: 22594542 MAIL ADDRESS: STREET 1: HAEMONETICS CORP STREET 2: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184-9144 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONMED Corp CENTRAL INDEX KEY: 0000816956 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 160977505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11311 CONCEPT BOULEVARD CITY: LARGO STATE: FL ZIP: 33773 BUSINESS PHONE: 727-214-2974 MAIL ADDRESS: STREET 1: 11311 CONCEPT BOULEVARD CITY: LARGO STATE: FL ZIP: 33773 FORMER COMPANY: FORMER CONFORMED NAME: CONMED CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-02 0000816956 CONMED Corp CNMD 0001261784 CONCANNON BRIAN C/O CONMED CORPORATION 11311 CONCEPT BOULEVARD LARGO FL 33773 1 Common Stock 2022-02-02 4 S 0 2027 135.09 D 13400 D Common Stock 2022-02-02 4 S 0 4200 136.96 D 9200 D Common Stock 2022-02-02 4 S 0 200 137.91 D 9000 D Common Stock 2022-02-02 4 M 0 2549 69.03 A 11549 D Common Stock 2022-02-02 4 S 0 2549 135.08 D 9000 D Common Stock 2022-02-02 4 M 0 2165 79.94 A 11165 D Common Stock 2022-02-02 4 S 0 2165 135.08 D 9000 D Common Stock 2022-02-02 4 M 0 1843 73.94 A 10843 D Common Stock 2022-02-02 4 S 0 1843 135.06 D 9000 D Common Stock 2022-02-02 4 M 0 1000 33.43 A 10000 D Common Stock 2022-02-02 4 F 0 241 139.03 D 9759 D Common Stock 2022-02-02 4 M 0 1000 39.64 A 10759 D Common Stock 2022-02-02 4 F 0 286 139.03 D 10473 D Common Stock 2022-02-02 4 M 0 1000 55.70 A 11473 D Common Stock 2022-02-02 4 F 0 401 139.03 D 11072 D Options To Purchase Common Stock 69.03 2022-02-02 4 M 0 2549 0 D 2019-06-01 2028-06-01 Common Stock 2549 0 D Options To Purchase Common Stock 79.94 2022-02-02 4 M 0 2165 0 D 2020-06-01 2029-06-03 Common Stock 2165 0 D Options To Purchase Common Stock 73.94 2022-02-02 4 M 0 1843 0 D 2021-06-01 2030-06-01 Common Stock 1843 0 D Sars (Stock Appreciation Rights) 33.43 2022-02-02 4 M 0 1000 0 D 2014-06-01 2023-07-26 Common Stock 1000 0 D Sars (Stock Appreciation Rights) 39.64 2022-02-02 4 M 0 1000 0 D 2015-06-01 2024-09-11 Common Stock 1000 0 D Sars (Stock Appreciation Rights) 55.70 2022-02-02 4 M 0 1000 0 D 2016-06-01 2025-06-01 Common Stock 1000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.29 to $137.06. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.88 to $137.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.84. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service. Sarah M. Oliker for Brian Concannon by Power of Attorney 2022-02-03